← Leaderboards
Godfrey D Pearlson
Johns Hopkins University
$40,766,686
Attributed
$49,385,954
Total exposure
32
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$49,385,954 · 32
By mechanism
R01$31,537,985 · 14
U01$8,309,045 · 1
R37$4,806,922 · 1
P50$3,526,506 · 7
RC1$996,533 · 1
P41$204,575 · 1
Top collaborators
- Michael C Stevens6 shared
- Pavlos Papasavas5 shared
- Christopher John Pittenger2 shared
- Sarah Yip2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Ryan G Vandrey$11,502,880
- Barry Setlow$7,849,023
- Daniel Ernest Ford$197,108,210
- Jennifer Lynn Bizon$9,186,341
- Brian Wilson Weir$124,356
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainResponsePatternCognitiveSchizophreniaFunctional Magnetic Resonance ImagingSamplingBaseAffectNeurobiologyNeuroimagingCognitionImpairmentLinkMagnetic Resonance ImagingImageGeneticImpulsivityParticipantStructureBehavioralNeural CircuitPerformancePharmaceutical Preparations
Grant awards (121)
IMPACT-MH: Clinical and behavioral fingerprints of psychopathology$4,149,937
U01 · FY2025 · MH
3/5 Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)$359,503
R01 · FY2025 · MH · contact PI
3/5 Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)$321,767
R01 · FY2025 · MH · contact PI
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor, Mavoglurant.$207,092
P50 · FY2025 · AA · contact PI
IMPACT-MH: Clinical and behavioral fingerprints of psychopathology$4,159,108
U01 · FY2024 · MH
3/5 Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)$359,503
R01 · FY2024 · MH · contact PI
3/5 Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)$321,767
R01 · FY2024 · MH · contact PI
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor, Mavoglurant.$207,092
P50 · FY2024 · AA · contact PI
3/5 Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)$359,503
R01 · FY2023 · MH · contact PI
3/5 Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)$321,767
R01 · FY2023 · MH · contact PI
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor, Mavoglurant.$207,092
P50 · FY2023 · AA · contact PI
Neuroimaging predictors of bariatric surgical outcomes$693,629
R01 · FY2022 · DK
3/5 Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)$359,503
R01 · FY2022 · MH · contact PI
3/5 Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)$338,642
R01 · FY2022 · MH · contact PI
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor, Mavoglurant.$192,782
P50 · FY2022 · AA · contact PI
Neuroimaging predictors of bariatric surgical outcomes$697,082
R01 · FY2021 · DK
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor, Mavoglurant.$410,101
P50 · FY2021 · AA · contact PI
3/5 Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)$376,378
R01 · FY2021 · MH · contact PI
Neuroimaging predictors of bariatric surgical outcomes$679,172
R01 · FY2020 · DK
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the Fyn Kinase Inhibitor Drug, Saracatinib.$121,615
P50 · FY2020 · AA · contact PI
3/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (BSNIP-2)$823,202
R01 · FY2019 · MH · contact PI
Neuroimaging predictors of bariatric surgical outcomes$665,405
R01 · FY2019 · DK
Neuroscience of Marijuana Impaired Driving$493,566
R01 · FY2019 · DA · contact PI
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the Fyn Kinase Inhibitor Drug, Saracatinib.$189,078
P50 · FY2019 · AA · contact PI
Neuroscience of Marijuana Impaired Driving$10,540
R01 · FY2019 · DA · contact PI
3/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (BSNIP-2)$909,025
R01 · FY2018 · MH · contact PI
Neuroscience of Marijuana Impaired Driving$567,823
R01 · FY2018 · DA · contact PI
Neuroimaging predictors of bariatric surgical outcomes$550,996
R01 · FY2018 · DK
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the Fyn Kinase Inhibitor Drug, Saracatinib.$191,258
P50 · FY2018 · AA · contact PI
3/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (BSNIP-2)$680,413
R01 · FY2017 · MH · contact PI
Neuroscience of Marijuana Impaired Driving$566,360
R01 · FY2017 · DA · contact PI
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the Fyn Kinase Inhibitor Drug, Saracatinib.$209,273
P50 · FY2017 · AA · contact PI
3/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (BSNIP-2)$159,664
R01 · FY2017 · MH · contact PI
3/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (BSNIP-2)$678,856
R01 · FY2016 · MH · contact PI
Neuroscience of Marijuana Impaired Driving$559,232
R01 · FY2016 · DA · contact PI
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the Fyn Kinase Inhibitor Drug, Saracatinib.$219,697
P50 · FY2016 · AA · contact PI
3/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (BSNIP-2)$783,297
R01 · FY2015 · MH · contact PI
Neuroscience of Marijuana Impaired Driving$676,005
R01 · FY2015 · DA · contact PI
3/4-Psychosis & Affective Research Domains and Intermediate Phenotypes (PARDIP)$256,574
R01 · FY2015 · MH · contact PI
RC3 Functional Neuroimaging of Alcoholism vulnerability: gultamate, reward, and$121,796
P50 · FY2015 · AA · contact PI
3/4-Psychosis & Affective Research Domains and Intermediate Phenotypes (PARDIP)$254,446
R01 · FY2014 · MH · contact PI
3/4-Psychosis & Affective Research Domains and Intermediate Phenotypes (PARDIP)$201,145
R01 · FY2014 · MH · contact PI
RC3 Functional Neuroimaging of Alcoholism vulnerability: gultamate, reward, and$148,266
P50 · FY2014 · AA · contact PI
3/4-Psychosis & Affective Research Domains and Intermediate Phenotypes (PARDIP)$271,084
R01 · FY2013 · MH · contact PI
RC3 Functional Neuroimaging of Alcoholism vulnerability: gultamate, reward, and$234,146
P50 · FY2013 · AA · contact PI
Quantitative Neuroimaging in Psychosis$654,486
R37 · FY2012 · MH · contact PI
Alcohol Use in College Students:Cognition and fMRI$537,683
R01 · FY2012 · AA · contact PI
Quantitative Neuroimaging in Psychosis$283,326
R37 · FY2012 · MH · contact PI
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes$218,218
R01 · FY2012 · MH · contact PI
RC3 Functional Neuroimaging of Alcoholism vulnerability: gultamate, reward, and$165,415
P50 · FY2012 · AA · contact PI
Quantitative Neuroimaging in Psychosis$656,324
R37 · FY2011 · MH · contact PI
Alcohol Use in College Students:Cognition and fMRI$552,484
R01 · FY2011 · AA · contact PI
RC3 Functional Neuroimaging of Alcoholism vulnerability: gultamate, reward, and$178,081
P50 · FY2011 · AA · contact PI
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes$822,018
R01 · FY2010 · MH · contact PI
Alcohol Use in College Students:Cognition and fMRI$673,045
R01 · FY2010 · AA · contact PI
Quantitative Neuroimaging in Psychosis$668,692
R37 · FY2010 · MH · contact PI
Genetic architecture of alcohol misuse candidate endophenotypes$497,595
RC1 · FY2010 · AA · contact PI
Schizophrenia Biomarkers: Memory Genes and fMRI$369,523
R01 · FY2010 · MH · contact PI
An fMRI Study of Ventral Striatal Deficits During Reward and Punishment$105,570
P50 · FY2010 · AA · contact PI
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes$816,426
R01 · FY2009 · MH · contact PI
Quantitative Neuroimaging in Psychosis$668,926
R37 · FY2009 · MH · contact PI
Alcohol Use in College Students:Cognition and fMRI$584,407
R01 · FY2009 · AA · contact PI
Genetic architecture of alcohol misuse candidate endophenotypes$498,938
RC1 · FY2009 · AA · contact PI
Reward, Impulsivity and Cocaine Addiction; fMRI Studies$391,455
R01 · FY2009 · DA · contact PI
Schizophrenia Biomarkers: Memory, Genes and fMRI$369,326
R01 · FY2009 · MH · contact PI
An fMRI Study of Ventral Striatal Deficits During Reward and Punishment$101,222
P50 · FY2009 · AA · contact PI
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes$818,067
R01 · FY2008 · MH · contact PI
Alcohol Use in College Students:Cognition and fMRI$640,680
R01 · FY2008 · AA · contact PI
Quantitative Neuroimaging in Psychosis$535,483
R37 · FY2008 · MH · contact PI
Reward, Impulsivity and Cocaine Addiction; fMRI Studies$382,517
R01 · FY2008 · DA · contact PI
Schizophrenia Biomarkers: Memory, Genes and fMRI$377,199
R01 · FY2008 · MH · contact PI
fMRI Imaging of Alcohol-Intoxicated Driving$229,838
R01 · FY2008 · AA · contact PI
An fMRI Study of Ventral Striatal Deficits During Reward and Punishment$103,919
P50 · FY2008 · AA · contact PI
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes$843,756
R01 · FY2007 · MH · contact PI
Quantitative Neuroimaging in Psychosis$535,483
R37 · FY2007 · MH · contact PI
Reward, Impulsivity and Cocaine Addiction; fMRI Studies$381,070
R01 · FY2007 · DA · contact PI
Schizophrenia Biomarkers: Memory, Genes and fMRI$376,985
R01 · FY2007 · MH · contact PI
fMRI Imaging of Alcohol-Intoxicated Driving$229,447
R01 · FY2007 · AA · contact PI
An fMRI Study of Ventral Striatal Deficits During Reward and Punishment$98,604
P50 · FY2007 · AA · contact PI
Quantitative Neuroimaging in Psychosis; DTI Studies$76,850
R37 · FY2007 · MH · contact PI
Reward, Impulsivity and Cocaine Addiction; fMRI Studies$412,264
R01 · FY2006 · DA · contact PI
Quantitative Neuroimaging in Psychosis$359,352
R37 · FY2006 · MH · contact PI
fMRI Imaging of Alcohol-Intoxicated Driving$235,907
R01 · FY2006 · AA · contact PI
An fMRI Study of Ventral Striatal Deficits During Reward and Punishment$114,407
P50 · FY2006 · AA · contact PI
NEUROIMAGING IN PSYCHOSIS & SCHIZOPHRENIA SEX DIFFERENCES IN BRAIN ABNORMALITIE$86,918
P41 · FY2006 · RR · contact PI
Quantitative Neuroimaging in Psychosis$368,000
R37 · FY2005 · MH
fMRI Imaging of Alcohol-Intoxicated Driving$247,705
R01 · FY2005 · AA
NEUROIMAGING IN PSYCHOSIS &SCHIZOPHRENIA SEX DIFFERENCES IN BRAIN ABNORMALITIE$60,176
P41 · FY2005 · RR
SCHIZOPHRENIA: SEX DIFFERENCES IN BRAIN ABNORMALITIES$347,648
R01 · FY2004 · MH
NEUROIMAGING IN PSYCHOSIS &SCHIZOPHRENIA SEX DIFFERENCES IN BRAIN ABNORMALITIES$57,481
P41 · FY2004 · RR
Risk taking Behavior and Personality: a functional MRI study$3,134
M01 · FY2004 · RR
Risk Taking Behavior and Personality$1,254
M01 · FY2004 · RR
QUANTITATIVE STRUCTURAL NEUROIMAGING IN PSYCHOSIS$665,594
R01 · FY2003 · MH
SCHIZOPHRENIA: SEX DIFFERENCES IN BRAIN ABNORMALITIES$428,800
R01 · FY2003 · MH
AGING, BRAIN IMAGING AND COGNITION$386,396
R01 · FY2003 · MH
QUANTITATIVE STRUCTURAL NEUROIMAGING IN PSYCHOSIS$690,572
R01 · FY2002 · MH
AGING, BRAIN IMAGING AND COGNITION$526,331
R01 · FY2002 · MH
SCHIZOPHRENIA: SEX DIFFERENCES IN BRAIN ABNORMALITIES$461,162
R01 · FY2002 · MH
QUANTITATIVE STRUCTURAL NEUROIMAGING IN PSYCHOSIS$84,613
R01 · FY2002 · MH
EFFECTS OF ORAL MARINOL ON TIME ESTIMATION AND REGIONAL CEREBRAL BLOOD FLOW$0
M01 · FY2002 · RR
FMRI AND IMPLICIT MEMORY$0
M01 · FY2002 · RR
ORAL MARINOL EFFECTS ON TIME AND CEREBRAL BLOOD FLOW$0
M01 · FY2002 · RR
COCAINE EFFECTS ON CEREBRAL BLOOD FLOW--OXYGEN 15 PET$0
M01 · FY2002 · RR
COCAINE EFFECTS ON CEREBRAL BLOOD FLOW--OXYGEN 15 PET$0
M01 · FY2002 · RR
AGING, BRAIN IMAGING AND COGNITION$524,767
R01 · FY2001 · MH
QUANTITATIVE STRUCTURAL NEUROIMAGING IN PSYCHOSIS$491,207
R01 · FY2001 · MH
SCHIZOPHRENIA: SEX DIFFERENCES IN BRAIN ABNORMALITIES$450,015
R01 · FY2001 · MH
FMRI AND IMPLICIT MEMORY$0
M01 · FY2001 · RR
ORAL MARINOL EFFECTS ON TIME AND CEREBRAL BLOOD FLOW$0
M01 · FY2001 · RR
EFFECTS OF ORAL MARINOL ON TIME ESTIMATION AND REGIONAL CEREBRAL BLOOD FLOW$0
M01 · FY2001 · RR
COCAINE EFFECTS ON CEREBRAL BLOOD FLOW--OXYGEN 15 PET$0
M01 · FY2001 · RR
COCAINE EFFECTS ON CEREBRAL BLOOD FLOW--OXYGEN 15 PET$0
M01 · FY2001 · RR
AGING, BRAIN IMAGING AND COGNITION$505,463
R01 · FY2000 · MH
QUANTITATIVE STRUCTURAL NEUROIMAGING IN PSYCHOSIS$456,969
R01 · FY2000 · MH
SCHIZOPHRENIA: SEX DIFFERENCES IN BRAIN ABNORMALITIES$432,566
R01 · FY2000 · MH
LATE ONSET SCHIZOPHRENIA AND ALLIED STATES--PET AND MRI$280,013
R01 · FY2000 · MH
FMRI AND IMPLICIT MEMORY$0
M01 · FY2000 · RR
EFFECTS OF ORAL MARINOL ON TIME ESTIMATION AND REGIONAL CEREBRAL BLOOD FLOW$0
M01 · FY2000 · RR
COCAINE EFFECTS ON CEREBRAL BLOOD FLOW--OXYGEN 15 PET$0
M01 · FY2000 · RR
COCAINE EFFECTS ON CEREBRAL BLOOD FLOW--OXYGEN 15 PET$0
M01 · FY2000 · RR
ORAL MARINOL EFFECTS ON TIME AND CEREBRAL BLOOD FLOW$0
M01 · FY2000 · RR